The National Medical Products Administration (NMPA) in China is responsible for the evaluation and approval of medical devices. When it comes to reviewing medical device evaluation content, the NMPA typically focuses on several key areas:

1. Safety and Efficacy: Ensuring that the device is safe for use and performs as intended. This involves clinical trials and studies that substantiate the claims made by the manufacturer.

2. Quality Management Systems (QMS): Evaluating whether the manufacturer has a robust QMS in place, compliant with international standards such as ISO 13485.

3. Registration Dossier: Reviewing the registration application, which includes technical documentation, product specifications, and labeling.

4. Post-Market Surveillance: Assessment of the manufacturer’s plans for monitoring the device's performance once it's on the market, which includes tracking adverse events and device recalls.

5. Risk Analysis: Analysis of potential risks associated with the device and the effectiveness of risk mitigations.

6. Preclinical and Clinical Evidence: Evaluation of any preclinical testing (like laboratory studies) and clinical evidence (trial data) supporting the device's safety and effectiveness.

If you need more specific information about the evaluation process, including the latest regulations or standards, feel free to ask!

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn